Molecular Diagnosis in Hymenoptera Allergy: Comparison of Euroline DPA-Dx and ImmunoCAP
Authors:
- Lluís MarquèsLMLluís Marquès
- Arantza VegaAVArantza Vega
- Federico de la RocaFRFederico de la Roca
- Carmen DomínguezCDCarmen Domínguez
- Víctor Soriano-GomisVSVíctor Soriano-Gomis
- Teresa AlfayaTATeresa Alfaya
- Laia Ferré-YbarzLFLaia Ferré-Ybarz
- José-María VegaJVJosé-María Vega
- Mario TubellaMTMario Tubella
- Berta Ruiz-LeónBerta Ruiz-León
Open Access
Abstract
The efficacy of Hymenoptera venom immunotherapy is contingent upon the accurate identification of the insect responsible for the allergic reaction. The techniques used to detect specific IgE suffer from difficulties due to the cross-reactivity between Hymenoptera venoms (false positives), diagnostic ability, and the limited availability of allergenic components (false negatives). In this study, we analyzed the discrepancies in the results obtained with Euroline® DPA-Dx and ImmunoCAP® in the diagnosis of allergic reactions due to Hymenoptera stings in 151 patients. The results (positive/negative) of ImmunoCAP® and Euroline® agreed in 77/151 (50.99%) cases; with 15/151 (9.93%) cases positive for the same insect, and 61/151 (40.4%) cases positive for multiple insects. When the results were used to decide which venom to use for immunotherapy, there was a statistically significant discrepancy for Polistes dominula (21.8% of cases with ImmunoCAP® compared to only 8.4% with Euroline®). The presence of Polistes venom phospholipase (Pol d 1) in Euroline® did not increase its ability to differentiate double sensitization to wasps. ImmunoCAP® and Euroline® exhibited comparable diagnostic performance in bee venom allergy. For vespid venom allergy—particularly involving Polistes species—ImmunoCAP® appeared to show a slight diagnostic advantage, although this finding should be interpreted with caution.Keywords
Funding Information
- Fundación de la Sociedad Española de Alergología e Inmunología Clínica
This publication has 21 references indexed in Scilit:
- Basophil activation test as alternative method to CAP-inhibition in patients with double sensitization to vespid venomsMolecular Immunology, 2022
- Prevalence of Pol d 1 Sensitization in Polistes dominula Allergy and Its Diagnostic Role in Vespid Double-PositivityThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA)Clinical and Translational Allergy, 2021
- Marker allergens in Hymenoptera venom allergy — Characteristics and potential use in precision medicineAllergo Journal International, 2020
- Advances in IgE Testing for Diagnosis of Allergic DiseaseThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergyAllergy, 2017
- Comparing sensitivity of Hymenoptera allergen components on different diagnostic assay systems: Comparing apples and oranges?Journal of Allergy and Clinical Immunology, 2017
- Sensitivity and specificity of Hymenoptera allergen components depend on the diagnostic assay employedJournal of Allergy and Clinical Immunology, 2016
- Molecular allergy diagnostics using multiplex assays: methodological and practical considerations for use in research and clinical routineAllergo Journal International, 2015
- Spiking venom with rVes v 5 improves sensitivity of IgE detection in patients with allergy to Vespula venomJournal of Allergy and Clinical Immunology, 2013